提高免疫检查点抑制剂的抗肿瘤反应和减少副作用
2023-6-2 08:28
阅读：974
提高免疫检查点抑制剂的抗肿瘤反应和减少副作用https://www.ebiotrade.com/newsf/2023-6/20230601090912709.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=42c6875b-bcf9-49f8-a574-f454c436cdc5
| 01. | Humans | 33 篇 | 78.571% |
| 02. | Animals | 22 篇 | 52.381% |
| 03. | Neoplasms | 18 篇 | 42.857% |
| 04. | Immunotherapy | 17 篇 | 40.476% |
| 05. | Immune Checkpoint Inhibitors | 15 篇 | 35.714% |
| 06. | Mice | 12 篇 | 28.571% |
| 07. | Female | 10 篇 | 23.810% |
| 08. | Programmed Cell Death 1 Receptor | 10 篇 | 23.810% |
| 09. | Tumor Microenvironment | 9 篇 | 21.429% |
| 10. | B7-H1 Antigen | 8 篇 | 19.048% |
转载本文请联系原作者获取授权，同时请注明本文来自许培扬科学网博客。
链接地址：https://wap.sciencenet.cn/blog-280034-1390241.html?mobile=1
收藏
当前推荐数：0
推荐到博客首页
网友评论0 条评论
